Calcific aortic stenosis: an update
The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Calcific aortic stenosis in the elderly is the number one cause of surgical valve replacement in the US and Europe. The incidence of calcific aortic stenosis is increasing as the general age of the population increases. For many years, rheumatic heart disease was the main cause of aortic valve disease. Over the last half century, however, there has been a change from a rheumatic etiology to a 'degenerative' mechanism because of the increase in access to health care in developed countries and the increasing age of the population in the US and Europe. For many years 'degenerative' aortic stenosis was thought to be caused by the passive accumulation of calcium on the surface of the aortic valve leaflet. Recent studies have demonstrated, however, that the etiology of aortic valve disease has a similar pathophysiology to that of vascular atherosclerosis, and that the treatment of this disease could be similar to that of chronic vascular atherosclerosis. This Review will discuss our current understanding of the pathophysiology, risk factors, cellular mechanisms, diagnosis and finally, future medical therapies for calcific aortic stenosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The pathobiology of calcific AS is complex and involves genetic factors, lipoprotein deposition and oxidation, chronic inflammation, osteoblastic transition of cardiac valve interstitial cells and active leaflet calcification”
From Calcific aortic stenosis (2016) · cites this paper as [23]
In the citing paper
“Now, there is compelling histopathologic and clinical data suggesting that calcific valve disease is, in fact, an active and multifaceted condition involving lipoprotein deposition, chronic inflammation, osteoblastic transition of valve interstitial cells and active leaflet calcification2223.”
From Calcific aortic stenosis (2016) · cites this paper as [23]
Citations
Cites
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176857 · Cited by 8,495
Self-citationClinical Factors Associated With Calcific Aortic Valve Disease
Stewart, B. F., Siscovick, D., Lind, B. K., Gardin, J. M., Gottdiener, J. S., Smith, V. E., Kitzman, D. W., & Otto, C. M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00563-3 · Cited by 2,029
Mutations in NOTCH1 cause aortic valve disease
Garg, V., Muth, A. N., Ransom, J. F., Schluterman, M. K., Barnes, R., King, I. N., Grossfeld, P. D., & Srivastava, D. (2005) · Nature · doi:10.1038/nature03940 · Cited by 1,509 · cited 1×
“These studies have identified polymorphisms in genes including NOTCH1 (homologous to the Drosophila Notch gene that regulates cell fate decisions during development), the vitamin D receptor gene, and the apolipoprotein E2 allele”
BackgroundPredictors of Outcome in Severe, Asymptomatic Aortic Stenosis
Rosenhek, R., Binder, T., Porenta, G., Lang, I., Christ, G., Schemper, M., Maurer, G., & Baumgartner, H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008313430903 · Cited by 1,338
Otto, C. M., Kuusisto, J., Reichenbach, D. D., Gown, A. M., & O'Brien, K. D. (1994) · Circulation · doi:10.1161/01.cir.90.2.844 · Cited by 1,315
Association of Aortic-Valve Sclerosis with Cardiovascular Mortality and Morbidity in the Elderly
Otto, C. M., Lind, B. K., Kitzman, D. W., Gersh, B. J., & Siscovick, D. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907153410302 · Cited by 1,283 · cited 1×
“Permission obtained from Lippincott Williams & Wilkins © Freeman RV and Otto CM (2005) Circulation 111: 3316–3326.”
MethodRahimtoola, S. H. (1989) · American Heart Journal · doi:10.1016/0002-8703(89)90685-6 · Cited by 1,257
Self-citationLindroos, M., Kupari, M., Heikkilä, J., & Tilvis, R. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90249-z · Cited by 1,160
A Randomized Trial of Intensive Lipid-Lowering Therapy in Calcific Aortic Stenosis
Cowell, S. J., Newby, D. E., Prescott, R. J., Bloomfield, P., Reid, J., Northridge, D. B., & Boon, N. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043876 · Cited by 1,146 · cited 1×
“The Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on Regression (SALTIRE) was the first prospective study to test the effect of statin therapy on this disease process”
BackgroundBone Formation and Inflammation in Cardiac Valves
Mohler, E. R., Gannon, F., Reynolds, C., Zimmerman, R., Keane, M. G., & Kaplan, F. S. (2001) · Circulation · doi:10.1161/01.cir.103.11.1522 · Cited by 1,049 · cited 1×
“Experimental in vivo and ex vivo models have demonstrated the critical features of aortic valve calcification, which include osteoblast expression, cell proliferation and atherosclerosis”
Background
Research works printed but not linked: 1
- Ross J Jr and Braunwald E (1968) Aortic stenosis. Circulation 38 (Suppl 1): S61–S67
Cited by
Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis
Rossebø, A. B., Pedersen, T. R., Boman, K., Brudi, P., Chambers, J. B., Egstrup, K., Gerdts, E., Gohlke-Bärwolf, C., Holme, I., Kesäniemi, Y. A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804602 · Cited by 1,644
Lindman, B. R., Clavel, M.-A., Mathieu, P., Iung, B., Lancellotti, P., Otto, C. M., & Pibarot, P. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.6 · Cited by 982
Yutzey, K. E., Demer, L. L., Body, S. C., Huggins, G. S., Towler, D. A., Giachelli, C. M., Hofmann-Bowman, M. A., Mortlock, D. P., Rogers, M. B., Sadeghi, M. M., et al. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.302523 · Cited by 371
Hachicha, Z., Dumesnil, J. G., & Pibarot, P. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.079 · Cited by 356
Arterial calcification and bone physiology: role of the bone–vascular axis
Thompson, B., & Towler, D. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.36 · Cited by 337
Lancellotti, P., Donal, E., Magne, J., Moonen, M., O'Connor, K., Daubert, J.-C., & Pierard, L. A. (2010) · Heart · doi:10.1136/hrt.2009.190942 · Cited by 321
“AS cannot be viewed as an isolated disease of the valve.”
BackgroundThe Regulation of Valvular and Vascular Sclerosis by Osteogenic Morphogens
Boström, K. I., Rajamannan, N. M., & Towler, D. A. (2011) · Circulation Research · doi:10.1161/circresaha.110.234278 · Cited by 257
Self-citationInflammation and the Osteogenic Regulation of Vascular Calcification: A Review and Perspective
Shao, J.-S., Cheng, S.-L., Sadhu, J., & Towler, D. A. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.134205 · Cited by 222
Hakuno, D., Kimura, N., Yoshioka, M., Mukai, M., Kimura, T., Okada, Y., Yozu, R., Shukunami, C., Hiraki, Y., Kudo, A., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40973 · Cited by 199
“Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility.”
BackgroundYingchoncharoen, T., Gibby, C., Rodriguez, L. L., Grimm, R. A., & Marwick, T. H. (2012) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.112.977348 · Cited by 178
“719 Calcific aortic stenosis (AS) is the most common cause of aortic valve (AV) disease in developed countries.(1) AS affects 2% to 3% of the North American population aged >65 years(2) and >4% aged >75 years.”
Gössl, M., Mödder, U. I., Atkinson, E. J., Lerman, A., & Khosla, S. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.019 · Cited by 169
“last development and activity on bone surfaces (4,5).”
BackgroundYang, X., Fullerton, D. A., Su, X., Ao, L., Cleveland, J. C., & Meng, X. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.09.052 · Cited by 162
“Macrohages, T-lymphocytes, and pro-inflammatory mediators uch as interleukin-1, transforming growth factor-beta, and umor necrosis factor-alpha have all been found in calcified uman heart valves (2).”
BackgroundNovel Aspects of Oxidative Stress in Cardiovascular Diseases
Heistad, D. D., Wakisaka, Y., Miller, J., Chu, Y., & Pena-Silva, R. (2009) · Circulation Journal · doi:10.1253/circj.cj-08-1082 · Cited by 159
Bossé, Y., Miqdad, A., Fournier, D., Pépin, A., Pibarot, P., & Mathieu, P. (2009) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.108.820795 · Cited by 148
Yang, X., Meng, X., Su, X., Mauchley, D. C., Ao, L., Cleveland, J. C., & Fullerton, D. A. (2009) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2009.06.024 · Cited by 142
Aortic Valve: Mechanical Environment and Mechanobiology
Arjunon, S., Rathan, S., Jo, H., & Yoganathan, A. P. (2013) · Annals of Biomedical Engineering · doi:10.1007/s10439-013-0785-7 · Cited by 119
“83 In the past, most of the studies were performed with chondrocytes, human umbilical vein cells, 49 osteoblasts, vascular smooth muscle 48 and AV ECs.”
BackgroundInhibitory Role of Notch1 in Calcific Aortic Valve Disease
Acharya, A., Hans, C. P., Koenig, S. N., Nichols, H. A., Galindo, C. L., Garner, H. R., Merrill, W. H., Hinton, R. B., & Garg, V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027743 · Cited by 112
“The etiology of calcific aortic valve disease (CAVD) is proposed to involve genetic and environmental factors, but the molecular mechanisms underlying the process of aortic valve calcification remain poorly understood [4–6].”
Role of oxidative stress in calcific aortic valve disease and its therapeutic implications
Greenberg, H. Z. E., Zhao, G., Shah, A. M., & Zhang, M. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab142 · Cited by 124
Numerical Methods for Fluid–Structure Interaction Models of Aortic Valves
Marom, G. (2014) · Archives of Computational Methods in Engineering · doi:10.1007/s11831-014-9133-9 · Cited by 102
Aortic valve calcification: basic science to clinical practice
Akat, K., Borggrefe, M., & Kaden, J. J. (2009) · Heart · doi:10.1136/hrt.2007.134783 · Cited by 103
Impact of hypertension and renin–angiotensin system inhibitors in aortic stenosis
Capoulade, R., Clavel, M., Mathieu, P., Côté, N., Dumesnil, J. G., Arsenault, M., Bédard, É., & Pibarot, P. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12169 · Cited by 97
Duan, B., Yin, Z., Hockaday Kang, L., Magin, R. L., & Butcher, J. T. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.03.007 · Cited by 95
Notch Signaling in Cardiac Development and Disease
MacGrogan, D., Nus, M., & de la Pompa, J. L. (2010) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(10)92011-5 · Cited by 114
Thériault, S., Dina, C., Messika-Zeitoun, D., Le Scouarnec, S., Capoulade, R., Gaudreault, N., Rigade, S., Li, Z., Simonet, F., Lamontagne, M., et al. (2019) · Circulation: Genomic and Precision Medicine · doi:10.1161/circgen.119.002617 · Cited by 90
Mechanisms of Function and Disease of Natural and Replacement Heart Valves
Schoen, F. J. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130257 · Cited by 88
“The most frequent gross developmental cardiovascular malformation in humans, congenital bicuspid aortic valve (BAV), is usually uncomplicated in early life but frequently eventuates in calcific aortic stenosis or regurgitation in later life; infective endocarditis along with aortic dilation and/or dissection are less…”
InfluentialHarling, L., Saso, S., Jarral, O. A., Kourliouros, A., Kidher, E. S., & Athanasiou, T. (2011) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2011.03.036 · Cited by 98
“Aortic valve replacement (AVR) for acquired calcific aortic stenosis (AS) is the most commonly performed valvular procedure in adult cardiac surgery [1].”
BackgroundThe effect of statins on valve function and calcification in aortic stenosis: a meta-analysis
Zhao, Y., Nicoll, R., He, Y. H., & Henein, M. Y. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.01.023 · Cited by 80
Perrotta, I., Russo, E., Camastra, C., Filice, G., Di Mizio, G., Colosimo, F., Ricci, P., Tripepi, S., Amorosi, A., Triumbari, F., et al. (2011) · Histopathology · doi:10.1111/j.1365-2559.2011.03977.x · Cited by 77
Manipulation of valve composition to elucidate the role of collagen in aortic valve calcification
Rodriguez, K. J., Piechura, L. M., Porras, A. M., & Masters, K. S. B. (2014) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-14-29 · Cited by 80
“In the native valve, collagen content decreases with age [16], and this event is accompanied by an increase in the prevalence of aortic valve calcification [17].”
BackgroundCalcium Signaling Pathway Genes RUNX2 and CACNA1C Are Associated With Calcific Aortic Valve Disease
Guauque-Olarte, S., Messika-Zeitoun, D., Droit, A., Lamontagne, M., Tremblay-Marchand, J., Lavoie-Charland, E., Gaudreault, N., Arsenault, B. J., Dubé, M.-P., Tardif, J.-C., et al. (2015) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.115.001145 · Cited by 72
“AS is the principal indication for valve replacement surgery in North America and Europe.6 In Canada and the United States, the cost of an aortic valve replacement surgery is estimated at $74 602 CAN7 and $190 194 USD,8 respectively.”
BackgroundAortic stenosis and diabetes mellitus: An ominous combination
Banovic, M. D., Athithan, L., & McCann, G. P. (2019) · Diabetes and Vascular Disease Research · doi:10.1177/1479164118820657 · Cited by 73
Aortic Stenosis, a Left Ventricular Disease: Insights from Advanced Imaging
Badiani, S., van Zalen, J., Treibel, T. A., Bhattacharyya, S., Moon, J., & Lloyd, G. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0753-6 · Cited by 74
Molecular mechanisms underlying the onset of degenerative aortic valve disease
Hakuno, D., Kimura, N., Yoshioka, M., & Fukuda, K. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0400-9 · Cited by 66
Insights into the use of biomarkers in calcific aortic valve disease.
Beckmann, E., Grau, J. B., Sainger, R., Poggio, P., & Ferrari, G. M. (2010) · PubMed · Cited by 83
Zito, C., Salvia, J., Cusmà-Piccione, M., Antonini‐Canterin, F., Lentini, S., Oreto, G., Bella, G. D., Montericcio, V., & Carerj, S. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.06.070 · Cited by 69
Swim Bladder as a Novel Biomaterial for Cardiovascular Materials with Anti‐Calcification Properties
Liu, J., Li, B., Jing, H., Wu, Y., Kong, D., Leng, X., & Wang, Z. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201901154 · Cited by 57
Nathaniel, S., Saligram, S., & Innasimuthu, A. L. (2010) · World Journal of Cardiology · doi:10.4330/wjc.v2.i6.135 · Cited by 64
Nadlonek, N. A., Lee, J. H., Reece, T. B., Weyant, M. J., Cleveland, J. C., Meng, X., & Fullerton, D. A. (2013) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2013.04.013 · Cited by 58
“Recently, however, we and others have demonstrated that calcific aortic stenosis may in fact be an active disease process; mechanisms of inflammation and osteogenesis appear to play important roles in the pathogenesis of aortic stenosis [1–6].”
Effect of Bisphosphonates on the Progression of Degenerative Aortic Stenosis
Innasimuthu, A. L., & Katz, W. E. (2011) · Echocardiography · doi:10.1111/j.1540-8175.2010.01256.x · Cited by 63
Vascular Calcification: A Perspective On An Imminent Disease Epidemic
Towler, D. A. (2008) · IBMS BoneKEy · doi:10.1138/20080298 · Cited by 54
Calcific Aortic Stenosis—A Review on Acquired Mechanisms of the Disease and Treatments
Zebhi, B., Lazkani, M., & Bark, D. L. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.734175 · Cited by 52
Notch Signaling in Cardiac Development and Disease
de la Pompa, J. L. (2009) · Pediatric Cardiology · doi:10.1007/s00246-008-9368-z · Cited by 51
Visualizing novel concepts of cardiovascular calcification
Hjortnaes, J., New, S. E. P., & Aïkawa, E. (2013) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.09.003 · Cited by 57
“…of the aortic valve, or calcific aortic valve disease (CAVD), progresses from mild thickening to severe calcification and leads to stiffening of the aortic valve leaflets, eventually causing left ventricular outflow obstruction and heart failure (Mohler, 2004; Rajamannan et al., 2007; Otto, 2008).”
BackgroundLeszczynska, A., O’Doherty, A., Farrell, E., Pindjáková, J., O’Brien, F. J., O’Brien, T., Barry, F., & Murphy, M. J. (2016) · Stem Cells · doi:10.1002/stem.2315 · Cited by 51
Song, R., Fullerton, D. A., Ao, L., Zhao, K., Reece, T. B., Cleveland, J. C., & Meng, X. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005364 · Cited by 48
“addition, multiple pro-inflammatory mediators have been identified in calcified human aortic valves.(46) Our previous studies demonstrate that exogenous and endogenous”
BackgroundOxidation, Inflammation, and Aortic Valve Calcification
Towler, D. A. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.044 · Cited by 50
Calcification and extracellular matrix dysregulation in human postmortem and surgical aortic valves
Gomez‐Stallons, M. V., Tretter, J. T., Hassel, K. R., Gonzalez-Ramos, O., AMOFA, D., Ollberding, N. J., Mazur, W. M., Choo, J. K., Smith, J. M., Kereiakes, D. J., et al. (2019) · Heart · doi:10.1136/heartjnl-2019-314879 · Cited by 49
Jenke, A., Kistner, J., Saradar, S., Chekhoeva, A., Yazdanyar, M., Bergmann, A., Rötepohl, M. V., Lichtenberg, A., & Akhyari, P. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00651.2019 · Cited by 48
Aortic sclerosis and mitral annulus calcification: a window to vascular atherosclerosis?
Lazaros, G. A., Toutouzas, K. P., Drakopoulou, M. I., Boudoulas, H. K., Stefanadis, C., & Rajamannan, N. M. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2013.811978 · Cited by 39
Self-citationSecreted Wnt Modulators in Symptomatic Aortic Stenosis
Askevold, E. T., Gullestad, L. L., Aakhus, S., Ranheim, T., Tønnessen, T., Solberg, O. G., Aukrust, P., & Ueland, T. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.002261 · Cited by 37
“Additional studies, with mechanistic emphasis, are needed to elucidate the pathogenic role of the Wnt signaling pathways in the development and progression of AS.”
BackgroundInfluentialLjungberg, J., Holmgren, A., Bergdahl, I. A., Hultdin, J., Norberg, M., Näslund, U., Johansson, B. H., & Söderberg, S. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.007160 · Cited by 41
Takkenberg, J. J. M., Rajamannan, N. M., Rosenhek, R., Kumar, A. S., Carapetis, J. R., & Yacoub, M. H. (2008) · PubMed · Cited by 36
Self-citationHinton, R. B. (2012) · Cardiology Research and Practice · doi:10.1155/2012/926975 · Cited by 38
Šram, M., Vrselja, Z., Lekšan, I., Ćurić, G., Selthofer-Relatić, K., & Radić, R. (2015) · International Journal of Endocrinology · doi:10.1155/2015/456293 · Cited by 31
Impact of global hemodynamic load on exercise capacity in aortic stenosis
Dulgheru, R., Magné, J., Capoulade, R., Davin, L., Vinereanu, D., Piérard, L., Pîbarot, P., & Lancellotti, P. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.01.205 · Cited by 31
“Indeed, arterial compliance is often reduced due to atherosclerosis and medial elastocalcinosis in AS patients [2].”
BackgroundDiabetes Mellitus and Its Implications in Aortic Stenosis Patients
Mouriño-Álvarez, L., Corbacho-Alonso, N., Sastre-Oliva, T., Corros-Vicente, C., Solís, J., Tejerina, T., Padial, L. R., & Barderas, M. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126212 · Cited by 34
“There are many similarities between the early inflammatory stages of this disease and atherosclerosis [3].”
BackgroundFernández‐Pisonero, I., López, J., Onecha, E., Dueñas, A. I., Maeso, P. A., Crespo, M. S., Román, J. A. S., & García‐Rodríguez, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109081 · Cited by 33
“Calcific aortic stenosis is the most frequent cause of aortic valve replacement in developed countries [1].”
BackgroundSpatiotemporal Complexity of the Aortic Sinus Vortex as a Function of Leaflet Calcification
Hatoum, H., & Dasi, L. P. (2019) · Annals of Biomedical Engineering · doi:10.1007/s10439-019-02224-1 · Cited by 30
Vascular Calcification: Is it rather a Stem/Progenitor Cells Driven Phenomenon?
Leszczynska, A., & Murphy, M. J. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00010 · Cited by 31
In vitro 3D model and miRNA drug delivery to target calcific aortic valve disease
van der Ven, C. F. T., Wu, P.-J., Tibbitt, M. W., van Mil, A., Sluijter, J. P. G., Langer, R., & Aïkawa, E. (2017) · Clinical Science · doi:10.1042/cs20160378 · Cited by 32
Heme in Cardiovascular Diseases: A Ubiquitous Dangerous Molecule Worthy of Vigilance
Guo, Y., Zhao, H., Lin, Z., Ye, T., Xu, D., & Zeng, Q. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.781839 · Cited by 29
Capoulade, R., Côté, N., Mathieu, P., Chan, K. L., Clavel, M.-A. A., Dumesnil, J. G., Teo, K. K., Tam, J. W., Fournier, D., Després, J., et al. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.03.025 · Cited by 37
Molecular Basis of Cardiovascular Disease
Liu, C. A., & Gotlieb, A. I. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374419-7.00014-7 · Cited by 26
Wang, D., Xiong, T., Yu, W., Liu, B., Wang, J., Xiao, K., & She, Q. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.650213 · Cited by 49
Finsen, A. V., Ueland, T., Sjaastad, I., Ranheim, T., Ahmed, M. S., Dahl, C. P., Askevold, E. T., Aakhus, S., Husberg, C., Fiane, A. E., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112172 · Cited by 24
Vadana, M., Cecoltan, S., Ciortan, L., Macarie, R. D., Mihaila, A. C., Tucureanu, M. M., Gan, A., Simionescu, M., Mânduțeanu, I., Droc, I., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073776 · Cited by 25
“Calcification is associated with a decrease in valve collagen content [26].”
BackgroundThe Pathogenesis and Treatment of the Valvulopathy of Aortic Stenosis: Beyond the SEAS
Elmariah, S., & Mohler, E. R. (2010) · Current Cardiology Reports · doi:10.1007/s11886-010-0089-6 · Cited by 28
“[15] and Caira et al.”
The Burden of Valvular Heart Disease
Mensah, G. A. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5892-2.00001-5 · Cited by 25
Markus, M. R. P., Lieb, W., Stritzke, J., Siewert, U., Troitzsch, P., Koch, M., Dörr, M., Felix, S. B., Völzke, H., Schunkert, H., et al. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304831 · Cited by 21
Warnock, J. N., Nanduri, B., Gamez, C. A. P., Tang, J. D., Koback, D., Muir, W. M., & Burgess, S. C. (2011) · International Journal of Inflammation · doi:10.4061/2011/176412 · Cited by 26
“, compression of the ECM, altered flow patterns), thus influencing valve cell behavior; and (3) hypertension may play a key role in the activation of several biological processes that induce aortic valve remodeling and disease [13].”
BackgroundMolecular Basis of Cardiovascular Disease
Gotlieb, A. I. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802761-5.00014-6 · Cited by 20
Bayram, A., Erdoğan, M., Ekşi, F., & Yamak, B. (2011) · The Anatolian Journal of Cardiology · doi:10.5152/akd.2011.057 · Cited by 20
“Recent studies have demonstrated, however, that the etiology of aortic valve disease has a similar pathophysiology to that of vascular atherosclerosis (11, 12).”
BackgroundThe impact of multiple stenosis and aneurysms on arterial diseases: A cardiovascular study
Uddin, M. N., Hoque, K. E., & Billah, M. M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26889 · Cited by 17
“The most common symptoms of stenosis are hypertension, cardiovascular and coronary artery disease in the world [4] and peripheral, cerebral, and aortic aneurysmal diseases are found in the human blood vessels.”
BackgroundEchocardiographic Evaluation of Calcific Aortic Stenosis in the Older Adult
Adegunsoye, A., Mundkur, M. L., Nanda, N. C., & Hage, F. G. (2011) · Echocardiography · doi:10.1111/j.1540-8175.2010.01363.x · Cited by 16
Update on the pathophysiology of aortic stenosis
Rajamannan, N. M. (2008) · European Heart Journal Supplements · doi:10.1093/eurheartj/sun013 · Cited by 21
“Calcific aortic stenosis (AS) is the most common valve disorder in the western world.(1) Calcification of an aortic valve was once thought to be a largely passive process, with serum calcium attaching to the surface of a valve leaflet, forming a nodule.”
BackgroundSelf-citationValvular Heart Disease: A Century of Progress
Sharma, S., Mehra, A., & Rahimtoola, S. H. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.03.027 · Cited by 17
Self-citationSchoenenberger, A. W., Werner, N., Bramlage, P., Martínez‐Sellés, M., Maggi, S., Bauernschmitt, R., Thoenes, M., Kurucova, J., Michel, J.-P., & Ungar, A. (2013) · European Geriatric Medicine · doi:10.1016/j.eurger.2013.10.001 · Cited by 16
“Aortic stenosis (AS) represents a significant healthcare burden in the elderly population [1–3].”
BackgroundLi, B., Jing, H., Sun, Z., Wang, X., Kong, D., Liu, J., Leng, X., & Wang, Z. (2021) · Smart Materials in Medicine · doi:10.1016/j.smaim.2021.07.001 · Cited by 16
Ungar, A., Bramlage, P., Thoenes, M., Zannoni, S., & Michel, J.-P. (2013) · European Geriatric Medicine · doi:10.1016/j.eurger.2013.04.007 · Cited by 17
“Senile, calcified aortic valve stenosis (AS) is the most common reason for valve replacement in Europe and the United States [1– 3].”
BackgroundMedical Therapy for Calcific Aortic Stenosis
Salas, M. J., Santana, O., Escolar, E., & Lamas, G. A. (2011) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248411416504 · Cited by 14
“There is evidence of osteoblast bone formation in the calcific aortic valve.(7) The presence of osteoblast-like cellular phenotype and upregulated receptors (present in normal bone formation-signaling pathway) may indicate that the valvular cells potentially differentiate into bone-forming cells.”
BackgroundXu, J., Nie, M., Li, J., Xu, Z., Zhang, M., Yan, Y., Feng, T., Zhao, X., & Zhao, Q. (2017) · Herz · doi:10.1007/s00059-017-4620-z · Cited by 13
Gajanana, D., Wheeler, D., Hsi, D. H., Kovach, R. C., & George, J. C. (2016) · Journal of Interventional Cardiology · doi:10.1111/joic.12330 · Cited by 14
Mid-term follow-up after aortic valve replacement with the Carpentier Edwards Magna Ease prosthesis
Rajab, T. K., Ali, J. M., Hernández‐Sánchez, J., Mackie, J., Grimaudo, V., Sinichino, S., Mills, C., Rana, B. S., Dunning, J. J., & Abu-Omar, Y. (2020) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-020-01248-2 · Cited by 12
Diabetes mellitus is associated with an increased incidence of aortic valve stenosis
Roderburg, C., Loosen, S. H., Luedde, T., Kostev, K., & Luedde, M. (2021) · Diabetes and Vascular Disease Research · doi:10.1177/14791641211033819 · Cited by 15
Houessou, U., Zamani, P., Manikpurage, H. D., Li, Z., Gaudreault, N., Dahmene, M., Dagenais, F., Couture, C., Clavel, M.-A., Pibarot, P., et al. (2025) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2025.01.018 · Cited by 11
Cheng, C., Chang, H., Huang, P.-J., Wang, W.-C., & Lin, S. (2017) · Journal of the mechanical behavior of biomedical materials/Journal of mechanical behavior of biomedical materials · doi:10.1016/j.jmbbm.2017.06.020 · Cited by 12
“Historically, this progressive process has been thought to be a passive “degenerative” or “senile” process because of the prolonged time-dependent “wear and tear” of the valve leaflets (Dweck et al., 2012; Rajamannan et al., 2007).”
BackgroundRole of Angiogenetic Factors in Cardiac Valve Homeostasis and Disease
Hakuno, D., Kimura, N., Yoshioka, M., & Fukuda, K. (2011) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-011-9317-8 · Cited by 12
Motovska, Z. J., Vichova, T., Doktorova, M., Laboš, M., Malý, M., & Widimský, P. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0423-2 · Cited by 13
“stenosis (CAS), with 80% progressing to symptoms requiring a surgery to prevent death and to improve quality of life [1,2].”
Human interstitial cellular model in therapeutics of heart valve calcification
He, C., Tang, H., Mei, Z., Li, N., Zeng, Z., Darko, K. O., Yin, Y., Hu, C. A., & Yang, X. (2017) · Amino Acids · doi:10.1007/s00726-017-2432-3 · Cited by 11
Kapelouzou, A., Kontogiannis, C., Tsilimigras, D. I., Georgiopoulos, G. A., Kaklamanis, L., Tsourelis, L., & Cokkinos, D. V. (2019) · Cytokine · doi:10.1016/j.cyto.2019.01.009 · Cited by 11
“Currently, histopathologic and clinical data suggest that calcific valve disease is, in fact, not a simple degenerative process, in which calcium passively accumulates on the valve cusps, but an active and multifaceted condition involving chronic inflammation, and active leaflet calcification [4,5].”
BackgroundNew understanding about calcific aortic stenosis and opportunities for pharmacologic intervention
Moura, L. M., Maganti, K., Puthumana, J. J., Rocha‐Gonçalves, F., & Rajamannan, N. M. (2007) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3282f0dae6 · Cited by 14
Self-citationDistinct Genetic Risk Profile in Aortic Stenosis Compared With Coronary Artery Disease
Trenkwalder, T., Maj, C., Al‐Kassou, B., Dębiec, R., Doppler, S. A., Musameh, M. D., Nelson, C. P., Dasmeh, P., Grover, S., Knoll, K., et al. (2024) · JAMA Cardiology · doi:10.1001/jamacardio.2024.3738 · Cited by 15
Pagoulatou, S., Adamopoulos, D. N., Rovas, G., Bikia, V., Müller, H., Giannakopoulos, G., Mauler‐Wittwer, S., Licker, M. J., Stergiopulos, N., & Noble, S. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.863968 · Cited by 9
“Aortic valve stenosis (AS) is the most common valvular heart disease in the Western world impacting significantly morbidity and mortality especially in the elderly population (8).”
Valerio, V., Keceli, G., Moschetta, D., Porro, B., Ciccarelli, M., Massaiu, I., Songia, P., Maione, A. S., Alfieri, V., Myasoedova, V. A., et al. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0133 · Cited by 10
“The AS, the end-stage phase of CAVS, is the third most common cardiovascular ailment after hypertension and coronary artery disease, being the most prevalent heart valve disorder in the western world (42, 57).”
Galli, E., Leguerrier, A., Flecher, E. M., Leclercq, C., & Donal, E. (2016) · Echocardiography · doi:10.1111/echo.13407 · Cited by 9
Shear-mediated ALK5 expression regulates endothelial activation
Pang, K. T., Ghim, M., Sarathchandra, P., Warboys, C. M., Yacoub, M. H., Chester, A. H., & Weinberg, P. D. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.12.058 · Cited by 8
TAVI as a threat to surgical practice: “much ado about nothing” or “the quiet before the storm”?
Tamburino, C., Capodanno, D., & Ussia, G. P. (2010) · Heart · doi:10.1136/hrt.2010.208983 · Cited by 7
“The extent of ageing of the population is expected to nearly double by 2025.(2) Two per cent of patients with aortic stenosis are symptomatic and therefore require early treatment to avoid rapid clinical worsening of the disease and a high chance of dying within a short period.”
Romano, C., Maiorana, E., Nusca, A., Circhetta, S., Silvestri, S., Schena, E., Ussia, G. P., & Massaroni, C. (2024) · IEEE Open Journal of Engineering in Medicine and Biology · doi:10.1109/ojemb.2024.3402151 · Cited by 7
“The typical course of AS includes a prolonged asymptomatic period, after which severe symptoms might appear once a significant reduction in stroke volume occurs over time [4], [5].”
BackgroundAortic Valve Segmentation using Deep Learning
Lai, K. W., Shoaib, M. A., Chuah, J. H., Nizar, M. H. A., Anis, S., & Ching, S. L. W. (2021) · IEEE-EMBS Conference on Biomedical Engineering and Sciences · doi:10.1109/iecbes48179.2021.9398738 · Cited by 8
Introduction to the Compendium on Calcific Aortic Valve Disease
Heistad, D. D., Shanahan, C. M., & Demer, L. L. (2013) · Circulation Research · doi:10.1161/circresaha.113.301833 · Cited by 7
“Lindman, Bonow, and Otto (9) incorporate these considerations into state-of-the-art clinical management of aortic stenosis, including risk assessment based on blood tests, calcium mass, and stress testing; explanations for how the classification of severity depends on functional and hemodynamic context; the approach t…”
BackgroundInfluential
Metadata
- Authors
- Rajamannan, N. M., Bonow, R. O., & Rahimtoola, S. H.
- Affiliations
- Northwestern University (US)
- Corresponding author
- Rahimtoola, Shahbudin H
- Venue
- Nature Clinical Practice Cardiovascular Medicine
- Published
- 2007-05
- Volume
- 4
- Issue
- 5
- Pages
- 254-262
- ISSN
- 1743-4297 (ISSN-L)
- 1743-4300
- OpenAlex
- W2028139616
- Cited by
- 176
- References
- 64
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 7 · 2023: 6 · 2022: 10 · 2021: 10 · 2020: 6 · 2019: 8 · 2018: 3 · 2017: 11 · 2016: 9 · 2015: 6 · 2014: 9 · 2013: 14 · 2012: 14
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Clinical Practice Cardiovascular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Aortic Disease and Treatment Approaches
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
- Keywords
- calcific aortic stenosis, aortic valve disease, pathophysiology, rheumatic heart disease, calcium deposition, risk factors, diagnosis, medical therapy, valve replacement, older adults
- MeSH terms
- Age Factors, Aortic Valve Stenosis, Calcinosis, Calcium, Diagnosis, Differential, Echocardiography, Europe, Heart Ventricles, Humans, Myocardium, Prognosis, Stroke Volume, United States, Incidence, Survival Rate, Disease Progression, Heart Valve Prosthesis Implantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.